Severe combined immunodeficiency disease
โ
Robertson Parkman; Erwin W Gelfand
๐
Article
๐
1991
๐
Elsevier Science
๐
English
โ 741 KB
Patients with severe combined immunodeficiency disease represent a model for the first clinical applications of gene therapy. Present attempts use insertion of the human adenosine deaminase gene into the peripheral blood T lymphocytes of patients who lack this gene. The ultimate treatment, however,